These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancer. Kaur S; Elkahloun AG; Singh SP; Chen QR; Meerzaman DM; Song T; Manu N; Wu W; Mannan P; Garfield SH; Roberts DD Oncotarget; 2016 Mar; 7(9):10133-52. PubMed ID: 26840086 [TBL] [Abstract][Full Text] [Related]
24. Cell signaling by urokinase-type plasminogen activator receptor induces stem cell-like properties in breast cancer cells. Jo M; Eastman BM; Webb DL; Stoletov K; Klemke R; Gonias SL Cancer Res; 2010 Nov; 70(21):8948-58. PubMed ID: 20940399 [TBL] [Abstract][Full Text] [Related]
25. RNA Polymerase II-Associated Factor 1 Regulates Stem Cell Features of Pancreatic Cancer Cells, Independently of the PAF1 Complex, via Interactions With PHF5A and DDX3. Karmakar S; Rauth S; Nallasamy P; Perumal N; Nimmakayala RK; Leon F; Gupta R; Barkeer S; Venkata RC; Raman V; Rachagani S; Ponnusamy MP; Batra SK Gastroenterology; 2020 Nov; 159(5):1898-1915.e6. PubMed ID: 32781084 [TBL] [Abstract][Full Text] [Related]
26. Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6-Abundant Breast Cancer Cells by Regulating γ-Secretase-Mediated Notch1 Activation in Caveolae. Hsu EC; Kulp SK; Huang HL; Tu HJ; Salunke SB; Sullivan NJ; Sun D; Wicha MS; Shapiro CL; Chen CS Neoplasia; 2015 Jun; 17(6):497-508. PubMed ID: 26152358 [TBL] [Abstract][Full Text] [Related]
27. Construction and application of a lung cancer stem cell model: antitumor drug screening and molecular mechanism of the inhibitory effects of sanguinarine. Yang J; Fang Z; Wu J; Yin X; Fang Y; Zhao F; Zhu S; Li Y Tumour Biol; 2016 Oct; 37(10):13871-13883. PubMed ID: 27485114 [TBL] [Abstract][Full Text] [Related]
28. Sanguinarine inhibits pancreatic cancer stem cell characteristics by inducing oxidative stress and suppressing sonic hedgehog-Gli-Nanog pathway. Ma Y; Yu W; Shrivastava A; Alemi F; Lankachandra K; Srivastava RK; Shankar S Carcinogenesis; 2017 Oct; 38(10):1047-1056. PubMed ID: 28968696 [TBL] [Abstract][Full Text] [Related]
29. Downregulation of CXCR7 inhibits proliferative capacity and stem cell-like properties in breast cancer stem cells. Tang X; Li X; Li Z; Liu Y; Yao L; Song S; Yang H; Li C Tumour Biol; 2016 Oct; 37(10):13425-13433. PubMed ID: 27460092 [TBL] [Abstract][Full Text] [Related]
30. Expression of the stem cell marker, Nanog, in human endometrial adenocarcinoma. Zhou X; Zhou YP; Huang GR; Gong BL; Yang B; Zhang DX; Hu P; Xu SR Int J Gynecol Pathol; 2011 May; 30(3):262-70. PubMed ID: 21464727 [TBL] [Abstract][Full Text] [Related]
31. Inhibiting epidermal growth factor receptor signalling potentiates mesenchymal-epithelial transition of breast cancer stem cells and their responsiveness to anticancer drugs. Manupati K; Dhoke NR; Debnath T; Yeeravalli R; Guguloth K; Saeidpour S; De UC; Debnath S; Das A FEBS J; 2017 Jun; 284(12):1830-1854. PubMed ID: 28398698 [TBL] [Abstract][Full Text] [Related]
32. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Chiou SH; Wang ML; Chou YT; Chen CJ; Hong CF; Hsieh WJ; Chang HT; Chen YS; Lin TW; Hsu HS; Wu CW Cancer Res; 2010 Dec; 70(24):10433-44. PubMed ID: 21159654 [TBL] [Abstract][Full Text] [Related]
33. Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas. Guo Y; Liu S; Wang P; Zhao S; Wang F; Bing L; Zhang Y; Ling EA; Gao J; Hao A Histopathology; 2011 Oct; 59(4):763-75. PubMed ID: 22014056 [TBL] [Abstract][Full Text] [Related]
34. Nr5a2 promotes cancer stem cell properties and tumorigenesis in nonsmall cell lung cancer by regulating Nanog. Ye T; Li J; Sun Z; Liu Y; Kong L; Zhou S; Tang J; Wang J; Xing HR Cancer Med; 2019 Mar; 8(3):1232-1245. PubMed ID: 30740909 [TBL] [Abstract][Full Text] [Related]
35. Dietary chemopreventative benzyl isothiocyanate inhibits breast cancer stem cells in vitro and in vivo. Kim SH; Sehrawat A; Singh SV Cancer Prev Res (Phila); 2013 Aug; 6(8):782-90. PubMed ID: 23661606 [TBL] [Abstract][Full Text] [Related]
36. Tumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR/Stat3/Sox-2 signaling pathway. Yang J; Liao D; Chen C; Liu Y; Chuang TH; Xiang R; Markowitz D; Reisfeld RA; Luo Y Stem Cells; 2013 Feb; 31(2):248-58. PubMed ID: 23169551 [TBL] [Abstract][Full Text] [Related]
38. PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth. Sharma N; Nanta R; Sharma J; Gunewardena S; Singh KP; Shankar S; Srivastava RK Oncotarget; 2015 Oct; 6(31):32039-60. PubMed ID: 26451606 [TBL] [Abstract][Full Text] [Related]
39. RNAi mediated silencing of Nanog expression suppresses the growth of human colorectal cancer stem cells. Zhang C; Zhao Y; Yang Y; Zhong C; Ji T; Duan J; Wang Y Biochem Biophys Res Commun; 2021 Jan; 534():254-260. PubMed ID: 33288197 [TBL] [Abstract][Full Text] [Related]
40. Mammary cancer chemoprevention by withaferin A is accompanied by in vivo suppression of self-renewal of cancer stem cells. Kim SH; Singh SV Cancer Prev Res (Phila); 2014 Jul; 7(7):738-47. PubMed ID: 24824039 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]